Marc Labrunee

Marc Labrunee

Auto-generated profile, based on publicly available information

Marc Labrunee

Polyclinique de l'Ormeau, 28 boulevard du 8-Mai-1945, 65000 Tarbes, France

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Annals of Physical and Rehabilitation Medicine
Verified
Journal Article
Closed access
FBFlorent Besnier
Florent Besnier
MLMarc Labrunée
Marc Labrunée
APAtul Pathak
Atul Pathak
ATAnne Pavy-Le Traon
Anne Pavy-Le Traon
CGCéline Galès
Céline Galès
TGThibaut Guiraud
Thibaut Guiraud

1 April 2012 in Journal Of Hypertension
Verified
Journal Article
Closed access
FDFabien Despas
Fabien Despas
ELElisabeth Lambert
Elisabeth Lambert
AVAngelica Vaccaro
Angelica Vaccaro
MLMarc Labrunee
Marc Labrunee
NFNicolas Franchitto
Nicolas Franchitto
APAtul Pathak
Atul Pathak
Chemoreflex-mediated sympathetic activation contributes to both initiation and progression of chronic heart failure (CHF). To study the direct role of increased peripheral chemosensitivity in reducing sympathetic baroreflex function in CHF patients, we compared sympathetic baroreflex function, assessed by the slope of the relationship between muscle sympathetic nerve activity (MSNA) and DBP, in CHF patients with augmented (n = 18) and normal (n = 20) peripheral chemosensitivity. Using a double-blind, randomized, vehicle-controlled study, we examined the effect of chemoreflex deactivation (by breathing 100% oxygen for 15 min) on sympathetic baroreflex function in CHF patients with elevated and with normal chemosensitivity. Baseline MSNA was elevated (60.6 ± 3.2 vs. 48.9 ± 3.7 bursts/min, P < 0.05) and sympathetic baroreflex function impaired (3.06 ± 0.55 vs. 5.51 ± 0.69 % bursts/mmHg, P < 0.05) in CHF patients with augmented peripheral chemosensitivity compared with controls. Administration of 100% oxygen led to a significant decrease in MSNA (from 60.5 ± 3.2 to 52.6 ± 3.2 bursts/min, P < 0.001) and increase in sympathetic baroreflex (from 2.95 ± 0.56 to 6.18 ± 0.77, P < 0.001) in CHF patients with enhanced chemoreflex sensitivity. In contrast, neither room air nor 100% oxygen changed MSNA, hemodynamics or sympathetic baroreflex function in CHF patients with normal chemosensitivity. We report for the first time that increased peripheral chemoreflex sensitivity directly decreases sympathetic baroreflex function in CHF patients. This interaction contributes to sympathetic overactivity and blunted sympathetic baroreflex function of CHF patients and may explain how chemoreceptors contribute to the bad prognosis of CHF patients.

25 March 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AVAngelica Vaccaro
Angelica Vaccaro
FDFabien Despas
Fabien Despas
CDClement Delmas
Clement Delmas
Olivier LairezOlivier Lairez
Olivier Lairez
ELElisabeth Lambert
Elisabeth Lambert
APAtul Pathak
Atul Pathak
The exact pathophysiology of Tako-Tsubo cardiomyopathy (TTC) remains unknown but a role for sympathetic hyperactivity has been suggested. Up to now, no direct evidence of sympathetic nerve hyperactivity has been established nor involvement of sympathetic baroreflex identified. The aim of our study was to determine, by direct sympathetic nerve activity (SNS) recording if sympathetic nervous system activity is increased and spontaneous baroreflex control of sympathetic activity reduced in patients with TTC. We included 13 patients who presented with TTC and compared their SNS activity and spontaneous baroreflex control of sympathetic activity with that of 13 control patients with acutely decompensated chronic heart failure. SNS activity was evaluated by microneurography, a technique assessing muscle sympathetic nerve activity (MSNA). Spontaneous baroreflex control of sympathetic activity was evaluated as the absolute value of the slope of the regression line representing the relationship between spontaneous diastolic blood pressure values and concomitant SNS activity. Control patients were matched for age, sex, left ventricular ejection fraction and creatinine clearance. The mean age of the patients with TTC was 80 years, all patients were women. There were no significant differences between the two groups of patients for blood pressure, heart rate or oxygen saturation level. TTC patients presented a significant increase in sympathetic nerve activity (MSNA median 63.3 bursts/min [interquartile range 61.3 to 66.0] vs median 55.7 bursts/min [interquartile range 51.0 to 61.7]; p = 0.0089) and a decrease in spontaneous baroreflex control of sympathetic activity compared to matched control patients (spontaneous baroreflex control of sympathetic activity median 0.7%burst/mmHg [interquartile range 0.4 to 1.9] vs median 2.4%burst/mmHg [interquartile range 1.8 to 2.9]; p = 0.005). We report for the first time, through direct measurement of sympathetic nerve activity, that patients with TTC exhibit elevated SNS activity associated with a decrease in spontaneous baroreflex control of sympathetic activity. These data may explain the pathophysiology and clinical presentation of patient with TTC.

1 December 2012 in Archives of Physical Medicine and Rehabilitation
Verified
Journal Article
Closed access
TGThibaut Guiraud
Thibaut Guiraud
RGRichard Granger
Richard Granger
VGVincent Gremeaux
Vincent Gremeaux
MBMarc Bousquet
Marc Bousquet
LRLisa Richard
Lisa Richard
APAtul Pathak
Atul Pathak

1 October 2013 in Medicine & Science in Sports & Exercise
Verified
Journal Article
Closed access
TGThibaut Guiraud
Thibaut Guiraud
MLMarc Labrunee
Marc Labrunee
KGKevin Gaucher-Cazalis
Kevin Gaucher-Cazalis
FDFabien Despas
Fabien Despas
PMPhilippe Meyer
Philippe Meyer
APAtul Pathak
Atul Pathak
Autonomic dysfunction including sympathetic activation and vagal withdrawal has been reported in patients with chronic heart failure (CHF). We tested the hypotheses that high-intensity interval exercise (HIIE) in CHF patients would enhance vagal modulation and thus decrease arrhythmic events. Eighteen CHF patients underwent a baseline assessment (CON) and were then randomized to a single session of HIIE and to an isocaloric moderate-intensity continuous exercise (MICE). We evaluated the HR, HR variability parameters, and arrhythmic events by 24-h Holter ECG recordings after HIIE, MICE, and CON sessions. We found that HR was significantly decreased after HIIE (68 ± 3 bpm, P < 0.01) when compared with CON and MICE values (71.1 ± 2 and 69 ± 3 bpm, respectively). HIIE led to a significant increase in normalized high-frequency power (35.95% ± 2.83% vs 31.56% ± 1.93% and 24.61% ± 2.62% for CON and MICE, respectively, P < 0.01). Both exercise conditions were associated with an increase in very low frequency power comparative to CON. After HIIE, premature ventricular contractions were significantly decreased (531 ± 338 vs 1007 ± 693 and 1671 ± 1604 for CON and MICE, respectively, P < 0.01). An association was found between the changes in premature ventricular contraction and the changes in low-frequency/high-frequency ratio (r = 0.66, P < 0.01) in patients exposed to HIIE. We demonstrate that a single session of HIIE improves autonomic profile of CHF patients, leading to significant reductions of HR and arrhythmic events in a 24-h posttraining period. Cardioprotective effects of HIIE in CHF patients need to be confirmed in a larger study population and on a long-term basis.

1 July 2012 in Annals of Physical and Rehabilitation Medicine
Verified
Journal Article
Closed access
TGThibaut Guiraud
Thibaut Guiraud
RGR. Granger
R. Granger
VGV. Gremeaux
V. Gremeaux
MBM. Bousquet
M. Bousquet
LRL. Richard
L. Richard
APA. Pathak
A. Pathak